de Castro Soares Gustavo Gomes, Marinho Carlos Hespanha, Pitol Regiane, Andretta Camila, Oliveira Edinaldo, Martins Cristina, Riella Miguel Carlos
Hospital Pilar, Avenida Hugo Simas, 322, Bom Retiro, Curitiba, PR, 80.520-250, Brazil.
Hospital Pilar, Avenida Hugo Simas, 322, Bom Retiro, Curitiba, PR, 80.520-250, Brazil.
Clin Nutr ESPEN. 2017 Dec;22:13-18. doi: 10.1016/j.clnesp.2017.08.006. Epub 2017 Sep 6.
BACKGROUND & AIMS: Among hospitalized patients receiving enteral nutrition (EN), malnutrition and antibiotic use are some of the most common causes of diarrhea. Prebiotics and probiotics agents have been used for treatment of diarrhea in such patients. The aim of this study was to assess the efficacy of a sporulated Bacillus strain (Bacillus cereus A 05), compared to a control group using a prebiotic (soluble fiber), in reducing diarrhea in patients receiving EN and antibiotic therapy.
Patients with diarrhea receiving EN were randomized to receive either B. cereus (study group) or soluble fiber (control group) for five days. The group treated with B. cereus received 4 vials with 5 mL × 10 every 6 h. The control group treated with fiber received 10 g of soluble fiber every 8 h. Data assessed were serum albumin, nutrition status through Subjective Global Assessment (SGA), antibiotic use and osmolality (normal or hyperosmolar) of the tube feeding diets.
Twenty-nine patients were treated in each group. There was no significant difference between the groups regarding age, serum albumin, SGA score, dietary osmolality and antibiotic use. There was no significant difference between groups in ceasing diarrhea. However, the group treated with B. cereus took fewer days to cease diarrhea (2.5 ± 1.3 versus 3.7 ± 1.1 days, p = 0.011). Specifically, in the group treated with B. cereus A 05, malnourished patients did better than non-malnourished patients regarding diarrhea cessation (100% versus 25%, p < 0.001).
B. cereus A 05 was more effective than fiber in reducing diarrhea among patients under EN and antibiotic therapy and was more effective among malnourished patients.
在接受肠内营养(EN)的住院患者中,营养不良和使用抗生素是腹泻的一些最常见原因。益生元和益生菌制剂已用于此类患者腹泻的治疗。本研究的目的是评估一种芽孢杆菌菌株(蜡样芽孢杆菌A 05)与使用益生元(可溶性纤维)的对照组相比,在减少接受EN和抗生素治疗患者腹泻方面的疗效。
腹泻且接受EN的患者被随机分为接受蜡样芽孢杆菌治疗组(研究组)或可溶性纤维治疗组(对照组),为期5天。蜡样芽孢杆菌治疗组每6小时接受4瓶5mL×10的制剂。纤维治疗的对照组每8小时接受10g可溶性纤维。评估的数据包括血清白蛋白、通过主观全面评定法(SGA)评估的营养状况、抗生素使用情况以及管饲饮食的渗透压(正常或高渗)。
每组治疗29例患者。两组在年龄、血清白蛋白、SGA评分、饮食渗透压和抗生素使用方面无显著差异。两组在腹泻停止方面无显著差异。然而,蜡样芽孢杆菌治疗组停止腹泻所需天数较少(2.5±1.3天对3.7±1.1天,p = 0.011)。具体而言,在蜡样芽孢杆菌A 05治疗组中,营养不良患者在腹泻停止方面比非营养不良患者表现更好(100%对25%,p < 0.001)。
在接受EN和抗生素治疗的患者中,蜡样芽孢杆菌A 05在减少腹泻方面比纤维更有效,且在营养不良患者中更有效。